Safety Profile and Metabolic Effects of 14 Days of Treatment with DIO-902: Results of a Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial in Patients with Type…
Overview of attention for article published in Clinical Therapeutics, June 2008
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (89th percentile)
-
High Attention Score compared to outputs of the same age and source (81st percentile)
Readers on
- mendeley
- 89 Mendeley